Metabolic follow-up at one year and beyond of women with gestational diabetes treated with insulin and/or oral hypoglycaemic agents: study protocol for the identification of a core outcomes set using a Delphi survey

BACKGROUND: Gestational diabetes (GDM) is associated with an increased lifetime risk for the development of glucose abnormalities, metabolic syndrome, cardiovascular disease, depression and tumours. Despite this high risk of additional comorbidities, there is no standardised approach to the long-ter...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Trials
Autors principals: Bogdanet, Delia, Egan, Aoife, Fhelelboom, Narjes, Biesty, Linda, Thangaratinam, Shakila, Dempsey, Eugene, Crowther, Caroline, Devane, Declan, Dunne, Fidelma
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6321696/
https://ncbi.nlm.nih.gov/pubmed/30611300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-018-3059-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars